Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Gynesonics Announces Publication of SAGE Global Registry Preliminary Results: Real-World Usage Corroborates the Safety and Applicability of Sonata Transcervical Fibroid Ablation
2 Gynesonics Announces Publication of Clinical Study Analysis Demonstrating Effectiveness of the Sonata System in Treating Submucous and Large Symptomatic Uterine Fibroids
3 Gynesonics Announces Centers for Medicare and Medicaid Services Final Rule Approves Ambulatory Surgery Centers as a Site of Service for Transcervical Uterine Fibroid Ablation with Device Intensive Designation
4 Gynesonics Announces Positive Payer Coverage Issued by Health Care Service Corporation (HCSC) for the Sonata Treatment
5 Gynesonics Announces $75 Million Financing
6 Gynesonics Announces Publications on Healthcare Economic Analyses Demonstrating Significant Facility and Payer Cost Savings When Performing the Sonata Treatment Compared to Hysterectomy and Myomectomy for Symptomatic Fibroids
7 Gynesonics Announces Full Launch of New Sonata 2 System at 48th AAGL Global Congress
8 Gynesonics Announces Five-Year Patient Outcomes with the Sonata System Published in Journal of Gynecologic Surgery
9 Gynesonics Announces Early Completion of Enrollment in the SONATA FDA Clincial Trial for Incision Free Treatment of Symptomatic Uterine Fibroids
10 Gynesonics Names Christopher M. Owens President, Chief Executive Officer